Organon & Co (NYSE:OGN) has a beta value of 0.85 and has seen 0.51 million shares traded in the recent trading session. The company, currently valued at $2.78B, closed the recent trade at $10.80 per share which meant it gained $0.17 on the day or 1.55% during that session. The OGN stock price is -113.89% off its 52-week high price of $23.10 and 3.24% above the 52-week low of $10.45. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.6 million shares traded. The 3-month trading volume is 3.63 million shares.
The consensus among analysts is that Organon & Co (OGN) is Buy stock at the moment, with a recommendation rating of 2.75. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.91.
Organon & Co (NYSE:OGN) trade information
Sporting 1.55% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the OGN stock price touched $10.80 or saw a rise of 4.51%. Year-to-date, Organon & Co shares have moved -27.65%, while the 5-day performance has seen it change -4.47%. Over the past 30 days, the shares of Organon & Co (NYSE:OGN) have changed -29.86%. Short interest in the company has seen 15.13 million shares shorted with days to cover at 3.75.
Wall Street analysts have a consensus price target for the stock at $24, which means that the shares’ value could jump 55.0% from the levels at last check today.. The projected low price target is $24.0 while the price target rests at a high of $24.0. In that case, then, we find that the latest price level in today’s session is -122.22% off the targeted high while a plunge would see the stock gain -122.22% from the levels at last check today..
Organon & Co (OGN) estimates and forecasts
The company’s shares have lost -38.80% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -1.82%.
4 analysts offering their estimates for the company have set an average revenue estimate of 1.52B for the current quarter. 4 have an estimated revenue figure of 1.55B for the next ending quarter. Year-ago sales stood 1.62B and 1.61B respectively for this quarter and the next, and analysts expect sales will shrink by -6.18% for the current quarter and -1.82% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.49% over the past 5 years. Earnings growth for 2025 is a modest -6.45% while over the next 5 years, the company’s earnings are expected to decrease by -0.16%.
OGN Dividends
Organon & Co is expected to release its next earnings report on 2025-Feb-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.12 at a share yield of 10.38%. The company’s dividend yield has gone up over the past 12 months.
Organon & Co (NYSE:OGN)’s Major holders
Insiders own 0.22% of the company shares, while shares held by institutions stand at 83.00% with a share float percentage of 83.18%. Investors are also buoyed by the number of investors in a company, with Organon & Co having a total of 921.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 32.58 million shares worth more than $674.39 million. As of 2024-06-30, BLACKROCK INC. held 12.6625% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 30.21 million shares as of 2024-06-30. The firm’s total holdings are worth over $625.41 million and represent 11.7429% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Core S&P Small-Cap ETF and Pacer Funds Trust-Pacer US Cash Cows 100 ETF . As of Mar 31, 2025 , the former fund manager holds about 6.17% shares in the company for having 15.93 shares of worth $172.07 million while later fund manager owns 11.13 shares of worth $120.26 million as of Jan 31, 2025 , which makes it owner of about 4.31% of company’s outstanding stock.
